A Specific Reduction in Aβ(1−42) vs. a Universal Loss of Aβ Peptides in CSF Differentiates Alzheimer's Disease From Meningitis and Multiple Sclerosis

A reduced concentration of Aβ(1−42) in CSF is one of the established biomarkers of Alzheimer's disease. Reduced CSF concentrations of Aβ(1−42) have also been shown in multiple sclerosis, viral encephalitis and bacterial meningitis. As neuroinflammation is one of the neuropathological hallmarks...

Descripción completa

Detalles Bibliográficos
Autores principales: Spitzer, Philipp, Lang, Roland, Oberstein, Timo J., Lewczuk, Piotr, Ermann, Natalia, Huttner, Hagen B., Masouris, Ilias, Kornhuber, Johannes, Ködel, Uwe, Maler, Juan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976781/
https://www.ncbi.nlm.nih.gov/pubmed/29881343
http://dx.doi.org/10.3389/fnagi.2018.00152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976781/
https://www.ncbi.nlm.nih.gov/pubmed/29881343
http://dx.doi.org/10.3389/fnagi.2018.00152

Ejemplares similares